Sign in

CIK 0001867096

  • Large accelerated filer

Xeris Biopharma Holdings, Inc.

Sign in to watch
Ticker
XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
871082097
Phone
+1 844-445-5704
Business address
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
  1. 4 Grant or award Director acquired 42,500 shares (grant or award)
  2. 4 Grant or award Director acquired 42,500 shares (grant or award)
  3. 4 Grant or award Director acquired 85,000 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award Shannon John Patrick Jr acquired 750,000 shares (grant or award)
  6. 4 Grant or award Edick Paul R acquired 750,000 shares (grant or award)
  7. 4 Grant or award Pieper Steven acquired 750,000 shares (grant or award)
  8. 4 Grant or award Chief Scientific Officer acquired 150,000 shares (grant or award)
  9. 4 Grant or award Hecht Beth acquired 350,000 shares (grant or award)
  10. 4 Grant or award JOHNSON KENNETH ERLAND acquired 100,000 shares (grant or award)
  11. 4 Open-market buy Edick Paul R bought 20,000 shares at $1.45 ($29,000)
  12. 4 Grant or award Director acquired 15,000 shares (grant or award)
  13. 4 Grant or award Director acquired 15,000 shares (grant or award)
  14. 4 Grant or award Director acquired 15,000 shares (grant or award)
  15. 4 Grant or award Director acquired 15,000 shares (grant or award)
  16. 4 Grant or award Director acquired 15,000 shares (grant or award)
  17. 4 Grant or award Director acquired 15,000 shares (grant or award)
  18. 4 Grant or award Director acquired 15,000 shares (grant or award)
  19. 4 Open-market buy Edick Paul R bought 100,000 shares at $1.40 ($140,380)
  20. 4 Open-market sale Chief Scientific Officer sold 11,228 shares at $2.42 ($27,158)

Page 7 of 9 · 178 filings